A Commercial Anti-TIF1γ ELISA Is Superior to Line and Dot Blot and Should Be Considered as Part of Routine Myositis-Specific Antibody Testing

A Commercial Anti-TIF1γ ELISA Is Superior to Line and Dot Blot and Should Be Considered as Part of Routine Myositis-Specific Antibody Testing

ObjectivesAnti-TIF1γ is an important autoantibody in the diagnosis of cancer-associated dermatomyositis and the most common autoantibody in juvenile onset dermatomyositis. Its reliable detection is important to instigate further investigations into underlying malignancy in adults. We previously show...

Full description

Bibliographic Details
Main Authors: Ben Mulhearn, Danyang Li, Fionnuala McMorrow, Hui Lu, Neil J. McHugh, Sarah L. Tansley
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-01-01
Series:Frontiers in Immunology
Subjects:
TIF1γ
cancer
autoantibodies
myositis
ELISA - enzyme-linked immunosorbent assay
myositis - diagnosis
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.804037/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.804037/full

Similar Items